Decision-making and Decision Support Among Emerging Adults With First Episode Psychosis

Completed · Not applicable

Conditions studied: Early Psychosis

In brief

The purpose of this study is to evaluate the impact of an antipsychotic medication decision aid and interpersonal and cognitive factors, such as attachment style and motivation, on emerging adults' ability to engage in shared decision making regarding their medications.

Key facts

Study ID

NCT04373590

Run by

Temple University

People needed

18

Starts

2019-02-27

Expected to finish

2020-08-30

Last updated by the study team

2021-02-15

Who can join

Age: 18 and older, up to 25. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Aged 18 to 25 years
• Experiencing early psychosis, defined as psychosis lasting 18 months or less between the time when threshold symptom criteria were reached (as determined by the admitting CSC program assessor) and the date of CSC program enrollment
• Planning to attend a medication appointment with a participating CSC psychiatrist
• Ability to speak and understand English
• Ability to provide informed consent as assessed by research staff using procedures discussed by Carpenter et al. (2000) including a demonstrated understanding and recall of study procedures, rather than passive consent, and allowance of repetition of study procedures until there is understanding and recall.

You may not qualify if…

• Have a legal guardian
• Have identified co-occurring dementia, delirium, or intellectual disability that will likely affect their ability to provide informed consent or participate in the data collection procedures.

Where it is running

• Psychosis Education, Assessment, Care and Empowerment (PEACE) — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.